HB 3904 Oklahoma House · 2026 Regular Session

Medicaid; authorizing flexible payment structures for prenatal, delivery, and postpartum care; effective date.

HB 3904 requires Oklahoma Medicaid to reimburse specific maternal health services for pregnant and postpartum women. It changes payment rules to separately cover prenatal, delivery, and postpartum care (instead of bundled payments), implements immediate presumptive eligibility for prenatal care, and adds reimbursement for depression screening, self-measured blood pressure monitoring, remote ultrasounds, and doula/community health worker services. The bill directs the Oklahoma Health Care Authority to adopt implementing rules and seek federal approvals, effective November 1, 2026. It directly affects Medicaid-covered pregnant and postpartum individuals in Oklahoma by expanding access to targeted health services.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2026
Committee Review
Apr 2026
House Passage
Mar 2026
Senate Passage
Governor
Introduced Feb 2, 2026 Last action Apr 16, 2026
Maddy AI version diff · 6 comparisons

What changed between versions

Floor (House) Floor (Senate) · 3 edits
MINOR
The bill was amended to transition from a House committee substitute to a Senate floor version, incorporating specific changes to the bill's title and effective date. The most significant substantive change is the shift in the effective date from an unspecified time to November 1, 2026, ensuring the new Medicaid payment rules take effect at the start of the next fiscal year. Additionally, the list of covered prenatal, delivery, and postpartum services was expanded to explicitly include continuous glucose monitors for gestational diabetes.
Scope change
The bill's scope regarding covered services was broadened by adding specific items like continuous glucose monitors to the list of reimbursable services.
TIMELINE

The effective date was changed to November 1, 2026, clarifying when the new payment rules will begin.

DEFINITION

The definition of covered services was updated to explicitly include continuous glucose monitors for gestational diabetes.

TECHNICAL

The document header was updated to reflect the Senate floor version, and the committee report section was altered to match Senate procedures.

Floor votes · House Mar 25, 2026

How they voted

8312
Passed · 5 other
Total votes 100
Mar 25, 2026
D Democratic18
18 Yea
100% Yea
R Republican82
65 Yea 12 Nay 5
79% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
19
Key actions
5
Committee
6
Apr 8, 2026
Committee
Referred to Appropriations
upper
Apr 8, 2026
Upper · Passed
Reported Do Pass Health and Human Services committee; CR filed
upper
Mar 26, 2026
Introduced
First Reading
upper
Mar 26, 2026
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 25, 2026
Committee
Referred for engrossment
lower
Mar 25, 2026
Lower · Passed
Third Reading, Measure passed: Ayes: 82 Nays: 12
lower
Mar 5, 2026
Lower · Passed
CR; Do Pass, amended by committee substitute Appropriations and Budget Committee
lower
Feb 17, 2026
Lower · Passed
Recommendation to the full committee; Do Pass, amended by committee substitute Appropriations and Budget Health Subcommittee
lower
Feb 3, 2026
Committee
Referred to Appropriations and Budget Health Subcommittee
lower
Feb 2, 2026
Introduced
First Reading
lower
2 primary · 0 co-sponsors

Sponsors